MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkin"

  • 2018 International Congress

    Clinical evaluation of genetic changes of polymerase chain reaction in patients with PD at early stage

    M. Salokhiddinov (Tashkent, Uzbekistan)

    Objective: To assess the clinical feature of genetic changes in PARK1 (α-synuclein) and PARK2 with the help of PCR in patients with Parkinson’s disease and…
  • 2018 International Congress

    Novel population-specific mutationsin PINK1 and Parkin genes from India

    A. Kishore, M. Sturm, A. Asok, C. Schulte, D. KP, S. Krishnan, O. Riess, M. Sharma (Trivandrum, India)

    Objective: To look for novel and population-specific genes for PD in 50 Indian families with Parkinson's disease Background: Till date, 138 mutations in PINK1 and…
  • 2018 International Congress

    Molecular-genetic nature of Parkinson’s disease in the East European cohort

    A. Ivashynka, S. Likhachev (Minsk, Belarus)

    Objective: Genetic testing of the Parkin gene in patients with Parkinson's Disease (PD) in the East European cohort from Belarus. Background: The diagnosis of Juvenile…
  • 2018 International Congress

    Diagnostic utility of a targeted resequencing technique of next generation sequencing in detecting copy number changes in PARK2

    NY. Kim, SK. Hong, YE. Kim, HI. Ma, YJ. Kim (Anyang, Republic of Korea)

    Objective: We investigate feasibility of Next Generation Sequencing (NGS) targeted sequencing technique using Ampliseq® technology by Ion PGM® to detect copy number variation mutation in…
  • 2018 International Congress

    The Parkinson’s Families Project: A family-based study of early onset and familial Parkinson’s disease

    M. Tan, A. Costantini, S. Lubbe, E. Brown, J. Bras, N. Wood, A. Schapira, J. Hardy, H. Morris (London, United Kingdom)

    Objective: The aim of this study is to identify new genetic variants that cause or predispose to Parkinson’s disease (PD). Our secondary aim is to…
  • 2018 International Congress

    Retinal and choroidal changes in autosomal recessive PD are similar to idiopathic PD

    A. Colpak, A. Agin, G. Yalcin-Cakmakli, S. Kadayifcilar, A. Bilgic, B. Eldem, B. Elibol (Ankara, Turkey)

    Objective: Our aim is to evaluate the structural changes in retina and choroid by Optical Coherence Tomography (OCT) in idiopathic Parkinson's disease (PD) and common…
  • 2018 International Congress

    Identification of putative serum biomarkers for parkin-related Parkinson’s disease by metabolome analysis

    T. Ogawa, T. Hatano, A. Okuzumi, S. Ueno, A. Mori, Y. Oji, M. Fujimaki, T. Koinuma, S. Saiki, N. Hattori (Tokyo, Japan)

    Objective: Parkin is known as the causative gene of autosomal recessive familial Parkinson’s disease (parkin-PD). It remains unclear how parkin dysfunction associates with the dopaminergic…
  • 2018 International Congress

    Characterization of the preclinical model parkinQ311X

    A. Ciammola, M. Regoni, D. Mercatelli, L. Croci, G. Serratto, S. Fasano, L. Murru, S. Novello, M. Pingue, V. Silani, G. Consalez, F. Valtorta, M. Passafaro, M. Morari, J. Sassone (Milan, Italy)

    Objective: To characterize the preclinical model parkinQ311X. Because the PARK2-associated disease in humans is characterized by juvenile onset and slow progression, in order to clarify…
  • 2017 International Congress

    Goal-Directed Movement in Idiopathic Parkinson’s Disease and the effect of Parkin Mutations

    C. Fearon, T. Munteanu, D. Birsanu, L. Newman, B. Quinlivan, i. killane, B. Magennis, J. Butler, R. Reilly, T. Lynch (Dublin 7, Ireland)

    Objective: To investigate goal-directed behavior in people with Parkinson’s disease (with and without Parkin mutations) and healthy controls using a computer based task. Background: In…
  • 2017 International Congress

    Improved Detection of Gait Abnormalities in Parkinson’s disease using an IMU Sensor-based System

    B. Shiwani, S. Roy, J. Kline, M. Saint-Hilaire, C. Thomas, M. Gennert, G. De Luca (Natick, MA, USA)

    Objective: To develop an automated system that uses a limited set of IMU sensors to improve the detection of gait abnormalities in Parkinson’s disease during…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley